New data from ECZTRA 6 show improved sleep quality, itch relief and quality of life among teenagers treating atopic dermatitis with the IL-13 inhibitor.
Society of Dermatology Physician Assistants
Results from a cross-sectional survey suggest consistent patient preferences for treatment outcomes and means of administration.
Advertisement
Savanna Perry, PA-C, founder of The PA Platform, discusses the strategies and goals that go into building an online audience as a healthcare professional.
New phase 3 extension data show the topical PDE-4 inhibitor provided skin clearance to a significant rate of patients with psoriasis.
Advertisement
Advertisement
Trending on HCPLive
1
Emerge Phase 3: DT120 Shows Rapid, Durable Relief in MDD
2
A Real-World Case: Initiating Ritlecitinib After Years of Untreated Disease
3
Key Clinical Practice Pearls in Atopic Dermatitis, With Elaine Siegfried, MD
4
FAACT's “Food Allergies in the City” Offers Clinicians a Window into Patients' Daily Life
5